Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

The method effectively measures drug impact on DHT levels in prostate treatments.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.